Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth
Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16%
Categories
Health Care
Suven Pharmaceuticals Ltd Q4FY23 results out, net profit grows by 35%
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. SPL
Sequent Scientific Limited Q4 FY23 Earnings Conference Call Insights
Key highlights from Sequent Scientific Limited (SEQUENT) Q4 FY23 Earnings Concall Q&A Highlights: [00:14:02] Vishwas asked about the utilization of the API
Glenmark Pharmaceuticals Limited Q4 FY23 Earnings Conference Call Insights
Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY23 Earnings Concall Q&A Highlights: [00:27:19] Tushar Manudhane at Motilal Oswal asked about the
Alkem Laboratories Ltd (ALKEM) Q4 FY23 Earnings Concall Transcript
Alkem Laboratories Ltd (NSE:ALKEM) Q4 FY23 Earnings Concall dated May. 19, 2023. Corporate Participants: Amit Khandelia -- Associate Vice President, Finance Sandeep Singh -- Managing Director
Divi’s Laboratories Ltd Q4 FY23 Earnings Conference Call Insights
Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:11:30] Tushar Manudhane from Motilal Oswal asked if backward
Sun Pharma Advanced Research Company Q4FY23 results out, revenue grows by 92%
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products. The company is
Gland Pharma Limited (GLAND) Q4 FY23 Earnings Concall Transcript
Gland Pharma Limited (NSE:GLAND) Q4 FY23 Earnings Concall dated May. 18, 2023. Corporate Participants: Sumanta Bajpayee -- Vice President, Finance and Investor Relations Srinivas
Zydus Lifesciences Ltd (ZYDUSLIFE) Q4 FY23 Earnings Concall Transcript
Zydus Lifesciences Ltd (NSE: ZYDUSLIFE) Q4 FY23 earnings concall dated May. 18, 2023 Corporate Participants: Ganesh Nayak -- Executive Director Sharvil Patel -- Managing Director Nitin
Zydus Lifescience Ltd Q4FY23 results out, revenue grows by 32%
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Shalby Ltd Q4FY23 results out, net profit grows by 40%
Shalby Ltd reported Total revenue for Q4 FY23 of ₹199 Crore, up from ₹163 Crore year on year depicting a growth of
Shalby Ltd Q4FY23 results out, revenue grows by 22%
Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of
Metropolis Healthcare Limited (METROPOLIS) Q4 FY23 Earnings Concall Transcript
Metropolis Healthcare Limited (NSE: METROPOLIS) Q4 FY23 earnings concall dated May. 16, 2023 Corporate Participants: Ameera Shah -- Managing Director Surendran Chemmenkotil -- Chief Executive Officer
Zydus Wellness Ltd (ZYDUSWELL) Q4 FY23 Earnings Concall Transcript
Zydus Wellness Ltd (NSE: ZYDUSWELL) Q4 FY23 earnings concall dated May. 17, 2023 Corporate Participants: Tarun Arora -- Chief Executive Officer and Whole Time
Max Healthcare Institute Ltd (MAXHEALTH) Q4 FY23 Earnings Concall Transcript
Max Healthcare Institute Ltd (NSE: MAXHEALTH) Q4 FY23 earnings concall dated May. 17, 2023 Corporate Participants: Abhay Soi -- Chairman and Managing Director Yogesh
Procter & Gamble Health Q4FY23 Earnings
P&G Health Ltd. manufactures and sells medications and chemicals. Financial Results: Procter & Gamble Health Limited reported Total Income for Q4FY23 of
Granules India Ltd (GRANULES) Q4 FY23 Earnings Concall Transcript
Granules India Ltd (NSE:GRANULES) Q4 FY23 Earnings Concall dated May. 16, 2023. Corporate Participants: Irfan Raeen -- Investor Relations Krishna Prasad -- Chairman and Managing Director
Max Healthcare Inst 4Q23; 85% Growth in Profit
Max Healthcare Institute’s revenue in Q4FY23 rose 26% to ₹ 1,637 crores. Consolidated Profit After Tax came at ₹ 320 crores in
Pfizer Limited Q4FY23 Earnings Story
Pharmaceutical product manufacture, marketing, trade, and export are all activities of Pfizer Ltd. It produces goods in-house and also works with several
Themis Medicare Ltd (THEMISMED) Q4 FY23 Earnings Concall Transcript
Themis Medicare Ltd (NSE: THEMISMED) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Sachin Patel -- Managing Director and Chief Executive Officer
Rainbow Children’s Medicare Ltd (RAINBOW) Q4 FY23 Earnings Concall Transcript
Rainbow Children's Medicare Ltd (NSE: RAINBOW) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Ramesh Kancharla -- Chairman and Managing Director Sanjeev